anonymous
Guest
anonymous
Guest
More and more offices switching. Is this a reflection on our lame company culture, especially when our senior leadership resorts to calling key writers?
More and more offices switching. Is this a reflection on our lame company culture, especially when our senior leadership resorts to calling key writers?
I'm going to guess that costing 30% less is the biggest factor. Saying once a day dosing is worth an extra 30K/yr makes me blush
The only perceived benefit Ingrezza has to offer anyone is once a day dosing. That is the entire game for you people. Austedo is better on every other feature. EVERY ONE. You guys know it. Your laughable 60mg dose is ridiculous. Trying to be like Austedo after 5 years. 80mg causes Parkinsonism and hospitalizations, and you know it because the FDA made you change your PI to reflect how awful it is. 60 mg is a joke. 40mg isn't efficacious enough. Keep lying to all the providers and leaving out important safety info when you detail them. They know what's going on.
The only perceived benefit Ingrezza has to offer anyone is once a day dosing. That is the entire game for you people. Austedo is better on every other feature. EVERY ONE. You guys know it. Your laughable 60mg dose is ridiculous. Trying to be like Austedo after 5 years. 80mg causes Parkinsonism and hospitalizations, and you know it because the FDA made you change your PI to reflect how awful it is. 60 mg is a joke. 40mg isn't efficacious enough. Keep lying to all the providers and leaving out important safety info when you detail them. They know what's going on.
The only perceived benefit Ingrezza has to offer anyone is once a day dosing. That is the entire game for you people. Austedo is better on every other feature. EVERY ONE. You guys know it. Your laughable 60mg dose is ridiculous. Trying to be like Austedo after 5 years. 80mg causes Parkinsonism and hospitalizations, and you know it because the FDA made you change your PI to reflect how awful it is. 60 mg is a joke. 40mg isn't efficacious enough. Keep lying to all the providers and leaving out important safety info when you detail them. They know what's going on.
Clin Trial dot gov - Study NCT03325010 - Pediatric Subjects With Tourette Syndrome
Participants received valbenazine once daily for 12 weeks. The starting dose was 20 mg for participants <50 kg at baseline and 40 mg for participants ≥50 kg at baseline, and could be escalated in increments of 20 mg every 2 weeks to a maximum of 60 mg for subjects <50 kg
Grasping to survive here....This place is a joke!
Teva douche bags have entered the chat lol. Are you guys that lame you have to come over to our company thread impersonating disgruntled Neurocrine reps that are having soo many adverse events after all these years. We had one drug up until last year and our company is still worth the same as your shitty company. Go back to your lame company, with your shit pay and suck your thumb like the good little generic company that you are.
So you are admitting that your a teva rep coming over here to comment?Those disgruntled posts are by your Neurocrine reps chief. Your product is shit and the only thing it has going for it is once a day dosing. It has all kinds of issues and you know that.
So you are admitting that your a teva rep coming over here to comment?
So you are admitting that your a teva rep coming over here to comment?
I'm going to guess that costing 30% less is the biggest factor. Saying once a day dosing is worth an extra 30K/yr makes me blush
Speaking of stealing the show, how much is the DTC helping us?